Loading…
Loading…
BIRMF does not currently pay a dividend.
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for BIRMF and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for BIRMF and 80,000+ other tickers.
See exactly how BIRMF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for BIRMF and 80,000+ other tickers.
BioRem Inc., an engineering firm specializing in clean technology, focuses on the development, production, distribution, and sale of advanced air purification systems. These systems are designed to effectively eliminate unpleasant odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). The company's offerings include biofilters for targeting odors, H2S, VOCs, and HAPs, as well as biotrickling filters specifically tailored for applications involving high concentrations of H2S or other water-soluble VOCs. Additionally, BioRem Inc. provides multi-stage systems for odor…
Shares of BioRem Inc. (CVE: BRM - Get Free Report) fell 2.4% on Friday. The company traded as low as C$2.01 and last traded at C$2.01. 20,144 shares were traded during mid-day trading, a decline of 67% from the average session volume of 61,262 shares. The stock had previously closed at C$2.06. BioRem Stock Performance
GUELPH, ON , May 28, 2024 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("BIOREM" or "the Company") today announced results for the three month period ended March 31, 2024. BIOREM's complete 2024 first quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).